FDA Grand Rounds
Vet-LIRN: How FDA’s Network of Veterinary Diagnostic Laboratories advance animal food safety and public health by conducting outbreak investigations and monitoring resistance in animal pathogens.
Thursday, December 12, 2019
12:00 p.m. - 1:00 p.m. EST
Register here for webcast (public attendees and FDA staff)
CE Credit Available
Presented by:
Renate Reimschuessel, VMD, PhD
Program Director, Veterinary Laboratory Investigation and Response Network (Vet-LIRN)
Center for Veterinary Medicine, FDA
About the Presentation:
The Veterinary Laboratory Investigation and Response Network (Vet-LIRN) was established in 2010 to build laboratory capacity for routine and emergency response. The objective of this network was to ensure that the 40 participating laboratories were ready, willing, and able to investigate emerging problems with animal feed and animal drugs by providing a rapid response to reports of adverse events.
The associated Vet-LIRN laboratories participate in the national initiative to Combat Antibiotic Resistant Bacteria (CARB) by collecting veterinary pathogens for antimicrobial susceptibility testing and sequencing. This program has provided a wealth of information to FDA, with the ultimate goal of detecting emerging issues and of fostering antimicrobial stewardship in veterinary settings.
The Network provides FDA with critical laboratory testing data from experts around the country by evaluating animal diagnostic samples. Cooperative agreements fund the network and enable these laboratories to serve as first responders in case investigations and emergency response activities when the ability to quickly track down and isolate a dangerous pathogen or chemical adulterant is critical. These activities forward FDA’s mission for food and feed safety.
You’ll learn from this FDA Animal Scientist:
- Key features and activities of the Vet-LIRN network
- Vet-LIRN’s case investigation process
- Vet-LIRN’s antimicrobial resistance monitoring program for veterinary pathogens.
To Register:
FDA Employees:
https://collaboration.fda.gov/ grand/ (adobe link for webcast)
No hay comentarios:
Publicar un comentario